Table 1 Epidemiological associations with PVL status

Age (median)

37

58

<0.001

Male

102 (72.3)

93 (62.8)

0.085

Indigenous

48 (34.0)

18 (12.2)

<0.001

Intravenous Drug Use

23 (16.3)

10 (6.8)

0.011

Haematological malignancy

0 (0)

6 (4.1)

0.016

Solid malignancy

2 (1.4)

14 (9.5)

0.003

Diabetes Mellitus

31 (22)

44 (29.7)

0.133

Immunosuppressive treatment

7 (5)

14 (9.5)

0.141

HIV positive

3 (2.1)

2 (1.4)

0.613

Pre-existing skin condition

4 (2.8)

4 (2.7)

0.945

Hospitalisation in the past year

50 (35.5)

92 (61.2)

<0.001

Long term care facility resident

2 (1.4)

22 (14.9)

<0.001

“Community acquired” infection

87 (61.7)

35 (23.6)

<0.001

“Healthcare associated” infection

46 (32.6)

78 (52.7)

<0.001

“Hospital acquired” infection

8 (5.7)

35 (23.6)

<0.001